MaxCyte Competitors and Similar CompaniesClear all
MaxCyte's competitors and similar companies include Miltenyi Biotec, Senda Biosciences and Twentyeight-Seven Therapeutics.
 MaxCyte MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. |  Miltenyi Biotec Miltenyi Biotec is a company that specializes in biomedical research and cell and gene therapy. |  Senda Biosciences Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes. |  Twentyeight-Seven Therapeutics Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases. | |
Founding Date | Founding Date 1998 | Founding Date 1989 | Founding Date 2017 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Gaithersburg, US HQ Alderley Edge, GB | Locations Bergisch Gladbach, DE HQ Sydney, AU Shanghai, CN Paris, FR Bielefeld, DE Cologne, DE Göttingen, DE see more | Locations Cambridge, US HQ | Locations Watertown, US HQ |
Employees | Employees 65 | Employees 3,0341% increase | Employees 16 | Employees 6 |
Financial | ||||
Revenue (est.) | Revenue (est.) $33m (FY, 2025) | Revenue (est.) €671.5m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $6.2m (FY, 2025) | Cost of goods €132.2m (FY, 2023) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $26.8m (FY, 2025) | Gross profit €539.4m (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($44.6m) (FY, 2025) | Net income €11.4m (FY, 2023) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 31.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 80m |
For sources of this data, please see the company profile
View Company Profiles
Miltenyi Biotec
HQ
Bergisch Gladbach, DE
Miltenyi Biotec is a company that specializes in biomedical research and cell and gene therapy.
View companySenda Biosciences
HQ
Cambridge, US
Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes.
View companyTwentyeight-Seven Therapeutics
HQ
Watertown, US
Employees
6
Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases.
View company